Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company founded in 1988 and headquartered in Bridgewater, New Jersey, focuses on rare diseases with investigational and approved therapies in pulmonary, inflammatory, and other…
HQ: Bridgewater, NJ, United States of Americawww.insmed.com
USD129.41+1.67%vs prev. close
Market snapshot
Price
USD129.41
Daily move
+1.67%
P/E
—
EPS TTM
-4.12
Dividend yield
—
Beta
0.82
Market cap
28.3B
Price history
INSM price
USD
No price history available
Next earnings
No upcoming earnings report scheduled in the next 6 months.
Peer comparison
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Insmed
INSM
Biotechnology
28.3
—
—
+2.5%
-2.2%
+32.3%
-7.2%
-11.2%
-25.6%
🔒
Subscribe to Equity Analytics to compare INSM with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.